Skip to main content
BKHA
NASDAQ Life Sciences

Black Hawk Pays $150,000 to Push Vesicor Merger Deadline to November 22

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Neutral
Importance info
7
Price
$4.9
Mkt Cap
$20.353M
52W Low
$3.7
52W High
$23
52W Position info
32% above low
Off High info
79% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

BKHA sits 32% above its 52-week low of $3.7 on light trading volume (0.1× avg).

Summary

On October 22, 2026, Black Hawk deposited $150,000 into its trust account to extend its business combination deadline by one month, to November 22, 2026, keeping the approved Vesicor merger alive.


Key Events · M&A and Partnerships · BKHA

  • Trust Extended One Month to November 22

    A $150,000 Extension Payment was deposited into the trust account on October 22, 2026, pushing the deadline to consummate an initial business combination from October 22, 2026 to November 22, 2026.

  • Extension Follows Approved Vesicor Merger

    Shareholders approved the Vesicor merger and related proposals on October 13, 2026, but the deal had not closed by the original October 22 deadline, which is what required this extension.

  • Thin Trust After October Redemptions

    The extension follows the redemption of 2,089,162 Class A shares for approximately $25.15M, which left an estimated $420,370 in trust — the pool this $150,000 payment tops up.

  • November 22 Deadline Is the Next Hurdle

    Should the merger not be completed by November 22, 2026, the company must fund another extension or liquidate and return remaining trust cash to public shareholders.


Analysis · BKHA · Life Sciences

The Vesicor merger won shareholder approval on October 13, 2026, yet it still has not closed, so Black Hawk deposited $150,000 into the trust account to buy one more month, moving the deadline from October 22 to November 22, 2026. That payment is the only thing standing between the company and a charter-mandated liquidation, and it follows an October redemption wave that left roughly $420,370 in the trust. The clock is now the whole story: absent a close by November 22, the company must either fund another extension or wind up and return the remaining trust cash to public holders.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BKHA was trading at $4.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.4M. The 52-week trading range was $3.70 to $23.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BKHA - Latest Insights

BKHA
Oct 13, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.48
Real-time Price: $4.90 info
Change: -$7.58 (-61%) info
Market Cap: $20.353M info
BKHA
Oct 06, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $12.28
Real-time Price: $4.90 info
Change: -$7.38 (-60%) info
Market Cap: $20.353M info
BKHA
Sep 24, 2026, 6:22 PM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $4.90 info
Change: -$7.29 (-60%) info
Market Cap: $20.353M info
BKHA
Sep 24, 2026, 6:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $4.90 info
Change: -$7.29 (-60%) info
Market Cap: $20.353M info
BKHA
Sep 24, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.19
Real-time Price: $4.90 info
Change: -$7.29 (-60%) info
Market Cap: $20.353M info